Status:
COMPLETED
Efficacy of Endoscopic Subureteral Injection for Vesicoureteral Reflux in Adults With Decreased Bladder Compliance
Lead Sponsor:
Samsung Medical Center
Conditions:
Vesicoureteral Reflux
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Endoscopic subureteral injection for vesicoureteral reflux has become an established alternative to ureter reimplantation in children. Some recent studies suggest that ESI can be also a primary treatm...
Eligibility Criteria
Inclusion
- Who is aged 18 and greater
- Who underwent endoscopic subureteral injection for vesicoureteral reflux
Exclusion
- Medical records of whom is not evaluabe
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT00815334
Start Date
October 1 2008
End Date
December 1 2008
Last Update
June 17 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710